To include your compound in the COVID-19 Resource Center, submit it here.
In U.S. Phase I dose-escalation testing at 3 sites, intravenous Endostatin treatment was
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury